DP

Diadema Partners Portfolio holdings

AUM $161M
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$161M
AUM Growth
+$35.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
94
New
Increased
Reduced
Closed

Top Buys

1 +$16M
2 +$14.5M
3 +$7.7M
4
TGTX icon
TG Therapeutics
TGTX
+$5.89M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$4.45M

Top Sells

1 +$12.7M
2 +$3.54M
3 +$3.5M
4
ARGX icon
argenx
ARGX
+$3.48M
5
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$2.65M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLNO icon
1
Soleno Therapeutics
SLNO
$3.48B
$23.8M 7.25%
284,152
+191,150
AMGN icon
2
Amgen
AMGN
$161B
$14.5M 4.43%
+52,100
TGTX icon
3
TG Therapeutics
TGTX
$5.5B
$13.4M 4.07%
371,448
+163,565
NBIX icon
4
Neurocrine Biosciences
NBIX
$13.9B
$11.8M 3.6%
94,042
+31,795
LLY icon
5
Eli Lilly
LLY
$720B
$11.5M 3.52%
14,816
-4,486
JAZZ icon
6
Jazz Pharmaceuticals
JAZZ
$8.25B
$11.1M 3.38%
104,473
+17,284
BMRN icon
7
BioMarin Pharmaceuticals
BMRN
$10.2B
$10.6M 3.23%
192,877
+140,000
PCVX icon
8
Vaxcyte
PCVX
$5.5B
$6.45M 1.96%
198,285
+105,900
VKTX icon
9
Viking Therapeutics
VKTX
$3.77B
$5.23M 1.59%
197,468
+93,347
VRTX icon
10
Vertex Pharmaceuticals
VRTX
$107B
$4.45M 1.36%
+10,000
PTGX icon
11
Protagonist Therapeutics
PTGX
$4.82B
$4.21M 1.28%
+76,185
GILD icon
12
Gilead Sciences
GILD
$152B
$3.33M 1.01%
+30,000
ARGX icon
13
argenx
ARGX
$51.9B
$3.29M 1%
5,974
-6,305
IMCR icon
14
Immunocore
IMCR
$1.69B
$3.28M 1%
104,384
+7,400
REGN icon
15
Regeneron Pharmaceuticals
REGN
$61.3B
$2.94M 0.9%
5,607
-24,221
RVMD icon
16
Revolution Medicines
RVMD
$10.1B
$2.91M 0.89%
+79,079
COGT icon
17
Cogent Biosciences
COGT
$2.29B
$2.82M 0.86%
392,213
SRRK icon
18
Scholar Rock
SRRK
$2.69B
$2.23M 0.68%
62,926
+5,003
ITOS
19
DELISTED
iTeos Therapeutics
ITOS
$2.06M 0.63%
+206,200
URGN icon
20
UroGen Pharma
URGN
$784M
$2.06M 0.63%
150,000
+73,780
RARE icon
21
Ultragenyx Pharmaceutical
RARE
$3.15B
$1.96M 0.6%
+53,985
VRDN icon
22
Viridian Therapeutics
VRDN
$1.98B
$1.71M 0.52%
122,061
-40,002
MRK icon
23
Merck
MRK
$212B
$1.58M 0.48%
+20,000
PCRX icon
24
Pacira BioSciences
PCRX
$1.03B
$1.41M 0.43%
58,926
+20,000
OLMA icon
25
Olema Pharmaceuticals
OLMA
$642M
$1.08M 0.33%
253,657
+153,657